Skip to Content

Futura Medical PLC FAMDF

Morningstar Rating
$0.51 +0.03 (6.25%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FAMDF is trading at a 540% premium.
Price
$0.48
Fair Value
$4.73
Uncertainty
Extreme
1-Star Price
$2.12
5-Star Price
$6.95
Economic Moat
Hsg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FAMDF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.48
Day Range
$0.460.51
52-Week Range
$0.152.70
Bid/Ask
$0.39 / $0.60
Market Cap
$153.74 Mil
Volume/Avg
5,480 / 24,902

Key Statistics

Price/Earnings (Normalized)
Price/Sales
36.72
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
12

Comparables

Valuation

Metric
FAMDF
ERGO
INDV
Price/Earnings (Normalized)
31.207.69
Price/Book Value
20.748.19241.91
Price/Sales
36.724.552.23
Price/Cash Flow
35.25
Price/Earnings
FAMDF
ERGO
INDV

Financial Strength

Metric
FAMDF
ERGO
INDV
Quick Ratio
1.461.720.68
Current Ratio
1.471.790.92
Interest Coverage
30.390.08
Quick Ratio
FAMDF
ERGO
INDV

Profitability

Metric
FAMDF
ERGO
INDV
Return on Assets (Normalized)
−48.25%17.36%12.41%
Return on Equity (Normalized)
−62.08%28.99%620.00%
Return on Invested Capital (Normalized)
−61.06%26.30%68.18%
Return on Assets
FAMDF
ERGO
INDV
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRDkyqjtvqwYkhs$590.5 Bil
VRTX
Vertex Pharmaceuticals IncRkhkjxlpLxhmck$113.8 Bil
REGN
Regeneron Pharmaceuticals IncGrbmbjvyRdxrcnh$106.5 Bil
MRNA
Moderna IncDdzvvsrTjxmc$58.7 Bil
BNTX
BioNTech SE ADRNtcfcqchJfsy$22.7 Bil
ARGX
argenx SE ADRFsbmyzqxNdl$21.8 Bil
ALNY
Alnylam Pharmaceuticals IncSkspswmzScrfnp$18.6 Bil
BMRN
Biomarin Pharmaceutical IncWwzfpkkGmrvxbl$14.3 Bil
INCY
Incyte CorpZscqxvpMmlvbzj$12.8 Bil
TECH
Bio-Techne CorpBvwtjskhMmvdhhl$12.4 Bil

Sponsor Center